IBD Big Cap 20 Analysis: 5 Promising Stocks From List
Posted on December 10, 2012 at 18:42 PM EST
The current market uptrend hasn't been that strong, as evidenced by the relatively short supply of powerful breakouts. Even so, the IBD Big Cap 20 screen is doing its part to provide top-rated stocks that are clearing consolidations. Celgene (CELG) delivered a new breakout Monday, clearing an 80.04 buy point from a cup-with-handle pattern. The biotech stock had been showing a possible entry at 81.34 from a cup-like structure or flat base, but in